Chronic subdural haematoma: modern management and emerging therapies

Nat Rev Neurol. 2014 Oct;10(10):570-8. doi: 10.1038/nrneurol.2014.163. Epub 2014 Sep 16.

Abstract

Chronic subdural haematoma (CSDH) is one of the most common neurological disorders, and is especially prevalent among elderly individuals. Surgical evacuation is the mainstay of management for symptomatic patients or haematomas exerting significant mass effect. Although burr hole craniostomy is the most widely practised technique worldwide, approximately 10-20% of surgically treated patients experience postoperative recurrence necessitating reoperation. Given the increasing incidence of CSDH in a growing elderly population, a need exists for refined techniques that combine a minimally invasive approach with clinical efficacy and cost-effectiveness. In addition, nonsurgical treatment modalities, such as steroids, are attracting considerable interest, as they have the potential to reduce postoperative recurrence or even replace the need for surgery in selected patients. This Review provides an overview of the contemporary management of CSDH and presents considerations regarding future approaches that could further optimize patient care and outcomes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use*
  • Anticoagulants / therapeutic use*
  • Craniotomy / methods*
  • Disease Management
  • Drainage
  • Hematoma, Subdural, Chronic / diagnosis
  • Hematoma, Subdural, Chronic / prevention & control*
  • Hematoma, Subdural, Chronic / therapy
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Recurrence

Substances

  • Adrenal Cortex Hormones
  • Anticoagulants
  • Platelet Aggregation Inhibitors